- Exchange: Berlin
- Sector: Health Care
- Industry: Health Care Facilities/Srvcs
- Sub-Industry: Health Care Services
Snapshot for Agenix Ltd (BJ2)
| Open: | 0.020 | Day's Range: | 0.020 - 0.020 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.021 | 52wk Range: | 0.012 - 0.097 | 1-Yr Rtn: | -79.35% |
Key Statistics for BJ2
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BJ2
Company Profile & Key Executives for BJ2
Agenix Ltd. is a biotechnology company. The Company produces a monoclonal antibody diagnostic for live blood clots, and holds the rights in China to develop hepatitis B therapies.
| Nicholas Weston "Nick"Chairman/CEO | Gary TaylorCFO/Secretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BJ2 News
-
Industry News
No stories found
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page